Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraTreatment OutcomeTissue DonorsGraft SurvivalBusulfanBone Marrow PurgingCombined Modality TherapyCyclophosphamideHistocompatibility TestingHematopoietic Stem CellsHistocompatibilityRecurrenceTransplantation, IsogeneicBone Marrow DiseasesRetrospective StudiesKidney TransplantationTime FactorsHematopoiesisImmunosuppressive AgentsRadiation ChimeraMice, Inbred C57BLLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow ExaminationFatal OutcomeLeukemia, Myeloid, AcuteSurvival AnalysisAcute DiseaseRemission InductionHematologic NeoplasmsGraft RejectionHepatic Veno-Occlusive DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaBone RemodelingPrognosisBone Marrow NeoplasmsTransplantation ImmunologyFollow-Up StudiesGraft vs Host ReactionLeukemia, MyeloidSurvival RateAntineoplastic Combined Chemotherapy ProtocolsImmunosuppressionLymphocyte DepletionStem Cell TransplantationLeukocyte TransfusionLymphoma, Non-HodgkinHeart TransplantationSevere Combined ImmunodeficiencyChimeraColony-Forming Units AssayT-LymphocytesHLA AntigensMyelodysplastic SyndromesDisease-Free SurvivalLung TransplantationCyclosporineActuarial AnalysisBone DensityHematologic DiseasesLymphocyte TransfusionHodgkin DiseaseNuclear FamilyCarmustineOrgan TransplantationPancytopeniaGraft vs Tumor EffectMethotrexateCell DifferentiationProspective StudiesGraft vs Leukemia EffectCytarabineLeukocyte CountCytomegalovirus InfectionsBone ResorptionSpleenGranulocyte Colony-Stimulating FactorMelphalanMice, Inbred BALB CPostoperative ComplicationsRisk FactorsEtoposideFlow CytometryLymphomaMultiple MyelomaVincristineCells, CulturedAntigens, CD34